Topic: Imclone Systems Inc.

Savient Pharma (SVNT) - a small cap biotech trading 50% below the 52 week high with an approved FDA drug with blockbuster potential - provides an...

10 Celebrity Tax Evaders

Tax evasion challenges the idea that any publicity is good publicity. Sure, an IRS indictment is a quick way for a celebrity face to get splashed...

How Crisis Communication Plans Work

The success of any business, utility or organization rests firmly on its reputation. That's why businesses, nonprofit organizations, governments...

The Rectangle Formation

The rectangle is a classical technical analysis pattern described by horizontal lines showing significant support and resistance. It can be...
Although it has been almost ten years since Martha Stewart made her fateful decision to sell her shares of ImClone Systems Incorporated, the misconception still persists among the public, and many journalists, that she went to prison because of insider trading violations ...

ImClone’s Waksal Is Back, Seeking Investors for New Venture

Sam Waksal, the founder of ImClone Systems who fell from grace before the company became $6.5 billion takeover property for Eli Lilly, is back in the biotech world, trying to raise $50 million for a start-up, according to TheStreet. Waksal (pictured ...

Icahn seeks to nominate 3 to Biogen board

BOSTON (Reuters) - Biogen Idec Inc < said on Thursday it has received notice from billionaire investor Carl Icahn that he intends to nominate three people to its board as he seeks to expand his influence at one of the world's biggest biotech ...
This 14 percent revenue growth was comprised of an increase of 7 percent due to higher volume, 3 percent due to higher prices, and 3 percent due to the impact of foreign exchange rates (numbers do not add due to rounding). The ...
Eli Lilly may well be the potential mystery bidder for ImClone, but whether or not a published report pegging it as the possible suitor is correct, the pharmaceuticals maker would be better served to stay away.. That level is below the potential ...
And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt.As Eli Lilly and Co.'s chairman and CEO, Lechleiter brings some of his childhood lessons to bear in leading ...